Header Logo

Connection

Roger Harrison to Phosphatidylserines

This is a "connection" page, showing publications Roger Harrison has written about Phosphatidylserines.
Connection Strength

1.095
  1. Phosphatidylserine targeted single-walled carbon nanotubes for photothermal ablation of bladder cancer. Nanotechnology. 2018 Jan 19; 29(3):035101.
    View in: PubMed
    Score: 0.599
  2. Annexin A5 as a targeting agent for cancer treatment. Cancer Lett. 2022 10 28; 547:215857.
    View in: PubMed
    Score: 0.205
  3. Anionic phospholipid expression as a molecular target in Listeria monocytogenes and Escherichia coli. Int J Antimicrob Agents. 2020 Dec; 56(6):106183.
    View in: PubMed
    Score: 0.181
  4. Annexin V-targeted enzyme prodrug therapy using cytosine deaminase in combination with 5-fluorocytosine. Cancer Lett. 2011 Aug 01; 307(1):53-61.
    View in: PubMed
    Score: 0.094
  5. A soluble tissue factor-annexin V chimeric protein has both procoagulant and anticoagulant properties. Blood. 2006 Feb 01; 107(3):980-6.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.